Morphic Holding, Inc. - Common Stock (NQ:MORF)

56.99 UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Morphic Holding, Inc. - Common Stock

< Previous 1 2 3 Next >

Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses

August 06, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFC, HMNF, MORF on Behalf of Shareholders

July 31, 2024

From Halper Sadeh LLC

Via GlobeNewswire

Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses

July 29, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, COFS, PFC, WSBC on Behalf of Shareholders

July 27, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AGR, MORF, DRQ, SHCR on Behalf of Shareholders

July 24, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, HUDA, ALE, DOMA on Behalf of Shareholders

July 23, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHCR, MORF on Behalf of Shareholders

July 20, 2024

From Halper Sadeh LLC

Via GlobeNewswire

MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF

July 19, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPR, MORF on Behalf of Shareholders

July 11, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, INFN, AMBC, BEST on Behalf of Shareholders

July 10, 2024

From Halper Sadeh LLC

Via GlobeNewswire

MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF

July 09, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Eli Lilly Finalizes Acquisition Agreement to Acquire Morphic for $3.2 Billion – InsideArbitrage

July 09, 2024

Via AB Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, MORF, AGR on Behalf of Shareholders

July 08, 2024

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Morphic Holding, Inc. (Nasdaq - MORF), Desktop Metal, Inc. (NYSE - DM), Alimera Sciences, Inc. (Nasdaq - ALIM), Avangrid, Inc. (NYSE - AGR)

July 08, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

MORF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Morphic Holding, Inc. Is Fair to Shareholders

July 08, 2024

From Halper Sadeh LLC

Via Business Wire

Morphic to Participate in Jefferies Global Healthcare Conference

May 31, 2024

From Morphic Therapeutic

Via GlobeNewswire

Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells

May 21, 2024

From Morphic Therapeutic

Via GlobeNewswire

Morphic to Participate in RBC Capital Markets Global Healthcare Conference

May 09, 2024

From Morphic Therapeutic

Via GlobeNewswire

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

April 25, 2024

From Morphic Therapeutic

Via GlobeNewswire

Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

April 02, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

March 26, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc. (NASDAQ:MORF)

March 20, 2024

From Abraham, Fruchter & Twersky, LLP

Via GlobeNewswire

Morphic Appoints Dr. Simon Cooper as Chief Medical Officer

March 19, 2024

Experienced Clinical Development Leader with Deep Experience in Immunology and Inflammatory Diseases

From Morphic Therapeutic

Via GlobeNewswire

Morphic to Participate in March Investor Conferences

March 05, 2024

From Morphic Therapeutic

Via GlobeNewswire

Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023

February 22, 2024

From Morphic Therapeutic

Via GlobeNewswire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors

January 11, 2024

From Law Offices of Howard G. Smith

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors

January 10, 2024

From Glancy Prongay & Murray LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors

January 04, 2024

From The Law Offices of Frank R. Cruz

Via Business Wire

Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 03, 2024

From Morphic Therapeutic

Via GlobeNewswire

Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors

December 01, 2023

From Robbins LLP

Via Business Wire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.